Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark Katz
Mark Katz
Celgene
Pomalidomide
Cancer research
Multiple myeloma
Dexamethasone
Immune system
2
Papers
59
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
2019
Leukemia
Chad C. Bjorklund
Jian Kang
Michael Amatangelo
Ann Polonskaia
Mark Katz
Hsiling Chiu
Suzana Couto
Maria Wang
Yan Ren
Maria Ortiz
Fadi Towfic
J. Erin Flynt
William E. Pierceall
Anjan Thakurta
Show All
Source
Cite
Save
Citations (57)
Mechanistic Insights of Pomalidomide Activity in Combination with Bortezomib and Dexamethasone in Multiple Myeloma and Immune Cells
2018
Blood
Mark Katz
Chad C. Bjorklund
Anjan Thakurta
Natalya Serbina
Show All
Source
Cite
Save
Citations (2)
1